[ad_1]
Pfizer: “Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years.”
Business Wire: “Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age.”
MSNBC: “Fauci reacts to Pfizer news: We hopefully will be vaccinating children ‘by the end of October.’”
Gallup: “In U.S., 55% Would Get COVID-19 Vaccine for Young Child.”
The New York Times: “The F.D.A. again warns parents not to get children under 12 vaccinated yet.”
American Academy of Pediatrics: “AAP: Don’t use COVID-19 vaccine off-label for children.”
Dawn G., Missouri.
Carrie S., California.
Anne Liu, MD, clinical associate professor, Department of Medicine, Division of Infectious Diseases, and Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology, Stanford University School of Medicine.
Michael Smith, MD, professor of pediatrics and member, Duke Human Vaccine Institute, Duke University School of Medicine.
[ad_2]
Source link
